Advertisement

Kenneth H. Kim, MD, to Lead Cedars-Sinai Women’s Cancer Program


Advertisement
Get Permission

Cedars-Sinai Cancer Center has announced that Kenneth H. Kim, MD, will direct its Division of Gynecologic Oncology. Dr. Kim also serves as Chair of the institution’s Committee for Oversight of Training and Education. The appointment reflects Dr. Kim’s breadth of experience, which involves novel treatments of gynecologic cancers, advances in robotic surgery, and education through postgraduate levels and beyond.

“Dr. Kim is an exceptional addition to our faculty,” said Dan ­Theodorescu, MD, PhD, Director of Cedars-Sinai Cancer. “His reputation as a physician-scientist and educator who has made major contributions to the field of gynecologic oncology will elevate the national reputations of both the Division of Gynecologic Oncology and the Cedars-Sinai Women’s Cancer Program.”

Kenneth H. Kim, MD

Kenneth H. Kim, MD

Dan ­Theodorescu, MD, PhD

Dan ­Theodorescu, MD, PhD

Building the Best Program

Dr. Kim noted that his chief goal for the Division of Gynecologic Oncology is to continue to increase the clinical trials Cedars-Sinai Cancer offers and expand access to increase the number of patients the center serves. “We currently perform the most surgical cases of this kind in California,” Dr. Kim added. “Our mission now is to build the best gynecology oncology program in the nation, focusing on research and training.”

To that end, Dr. Kim is incorporating additional comprehensive training in both the medical and immunotherapeutic treatments of patients and continuing to train fellows in the most advanced surgical techniques and technologies in managing women’s cancers. “The Division of Gynecologic Oncology at Cedars is already a collection of truly top-notch, nationally and internationally recognized experts,” Dr. Kim said. “I look forward to taking it to the next level.”

Several clinical trials are imminent in the Division of Gynecologic Oncology, Dr. Kim said, including a “unique study” he hopes will improve the way patients are tested and screened for human papillomavirus (HPV). Researchers are evaluating a self-collection test, which may help identify HPV earlier for those with limited access to care. This work is a large multidisciplinary effort with Cedars-Sinai Cancer researchers in the Cancer Prevention & Control Program.

Dr. Kim, who also is the Board of Governors Endowed Chair in Gynecologic Oncology, said that Cedars-Sinai Cancer’s pioneering fellowship training program in gynecologic oncology—which began in the early 1970s—played a key role in his decision to join the Cedars-Sinai faculty. “In medicine, learning is a team sport in which there are people with varying levels of skill and experience who need mentoring, no matter their level,” Dr. Kim said. “My goal is always to support and guide the team, so everyone understands the ‘why’ and the ‘how’ behind what we’re doing, especially the patient.”

 


Advertisement

Advertisement



Advertisement